tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Keith Devas, 12 are a BUY (66.67%), 6 are a HOLD (33.33%).
Analyst Keith Devas, currently employed at JEFFERIES, carries an average stock price target met ratio of 27.5% that have a potential upside of 6.55% achieved within 15 days.
Keith Devas’s has documented 36 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KVUE, Kenvue at 30-Jan-2026.
Analyst best performing recommendations are on IDXX (IDEXX LABORATORIES).
The best stock recommendation documented was for KVUE (KENVUE) at 1/30/2026. The price target of $18 was fulfilled within 14 days with a profit of $1.39 (8.37%) receiving and performance score of 5.98.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Jan-2026
$710
$191.61 (36.96%)
$800
1 months 26 days ago
(11-Aug-2026)
0/3 (0%)
$123.36 (21.03%)
Hold Since 15-Apr-2026
$670
$151.61 (29.25%)
$650
2 months 2 days ago
(05-Aug-2026)
0/2 (0%)
$85.22 (14.57%)
Hold Since 01-Oct-2025
$670
$151.61 (29.25%)
$620
2 months 2 days ago
(05-Aug-2026)
2/6 (33.33%)
$85.22 (14.57%)
27
Buy Since 03-Nov-2025
$675
$123.5 (22.39%)
$775
6 months 6 days ago
(31-Mar-2026)
22/24 (91.67%)
$113.11 (20.13%)
145
Buy Since 25-Jul-2024
$800
$281.61 (54.32%)
$800
7 months 14 days ago
(23-Feb-2026)
21/25 (84%)
$176.87 (28.38%)
135
What Year was the first public recommendation made by Keith Devas?
